Omega Historical Cash Flow
| OMGA Stock | USD 0.52 0.04 7.29% |
Analysis of Omega Therapeutics cash flow over time is an excellent tool to project Omega Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 64 M or Other Cashflows From Financing Activities of 171 K as it is a great indicator of Omega Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Omega Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Omega Therapeutics is a good buy for the upcoming year.
Omega |
About Omega Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Omega balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Omega's non-liquid assets can be easily converted into cash.
Omega Therapeutics Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Omega Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Omega Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Omega Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Omega Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.At present, Omega Therapeutics' Investments are projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 10.6 M, whereas Change In Cash is projected to grow to (1.9 M).
| 2024 | 2025 (projected) | Stock Based Compensation | 10.1M | 10.6M | Net Borrowings | 9.2M | 7.3M |
Omega Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Omega Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omega Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (1.8M) | (38.9M) | (16.7M) | 63.0M | 72.5M | 76.1M | |
| Change In Cash | 20.7M | 163.5M | (115.9M) | (2.2M) | (2.0M) | (1.9M) | |
| Stock Based Compensation | 637K | 3.2M | 7.8M | 8.8M | 10.1M | 10.6M | |
| Free Cash Flow | (27.9M) | (59.1M) | (99.9M) | (94.4M) | (84.9M) | (89.2M) | |
| Change In Working Capital | 1.6M | 4.7M | (9.9M) | (9.4M) | (8.4M) | (8.0M) | |
| Begin Period Cash Flow | 2.6M | 23.3M | 186.8M | 71.0M | 81.6M | 64.0M | |
| Other Cashflows From Financing Activities | 48.6M | 122.3M | 708K | 200K | 180K | 171K | |
| Depreciation | 1.1M | 1.4M | 5.2M | 6.8M | 7.8M | 8.2M | |
| Other Non Cash Items | (59K) | 106K | 1.1M | (280K) | (322K) | (305.9K) | |
| Capital Expenditures | 1.8M | 1.5M | 1.4M | 2.9M | 3.3M | 1.8M | |
| Total Cash From Operating Activities | (26.1M) | (57.6M) | (98.5M) | (91.5M) | (82.4M) | (86.5M) | |
| Net Income | (29.4M) | (68.3M) | (102.7M) | (97.4M) | (87.7M) | (92.1M) | |
| Total Cash From Financing Activities | 48.6M | 261.5M | 708K | 41.8M | 48.1M | 80.2M | |
| End Period Cash Flow | 23.3M | 186.8M | 71.0M | 68.8M | 79.1M | 77.5M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Omega Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Therapeutics Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omega Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade Omega Stock refer to our How to Trade Omega Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 1.812 | Return On Assets | Return On Equity |
The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omega Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.